Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)

SHA:600572 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	6,515	6,652	5,945	6,531	5,863
Other Revenue	-	80.59	54.95	37.67	46.16
Revenue	6,515	6,733	6,000	6,568	5,909
Revenue Growth (YoY)	-3.23%	12.21%	-8.64%	11.15%	-12.70%
Cost of Revenue	3,053	2,835	2,470	2,626	2,088
Gross Profit	3,462	3,897	3,531	3,942	3,821
Selling, General & Admin	2,480	2,832	2,581	2,964	2,967
Research & Development	300.02	298.09	195.72	202.49	184.99
Other Operating Expenses	-31.86	64.89	62.99	64.65	75.31
Operating Expenses	2,748	3,196	2,840	3,268	3,239
Operating Income	714.24	700.94	690.41	674.18	581.56
Interest Expense	-	-36.4	-49.47	-73.22	-123.65
Interest & Investment Income	66.19	135.27	89.35	2,611	302.83
Currency Exchange Gain (Loss)	-	-1.03	-1.11	0.06	-6.16
Other Non Operating Income (Expenses)	-1.46	3.09	-3.76	-9.31	-1.09
EBT Excluding Unusual Items	778.96	801.87	725.42	3,203	753.5
Impairment of Goodwill	-	-	-	-	-52.99
Gain (Loss) on Sale of Investments	30.27	-146.04	-238.23	-714.69	34.63
Gain (Loss) on Sale of Assets	20.55	35.12	36.02	42.22	-4.86
Asset Writedown	-49.84	-6.63	-1.84	-95.71	-48.15
Other Unusual Items	-	83.36	68.64	92.55	83.52
Pretax Income	779.94	767.69	590.01	2,527	765.65
Income Tax Expense	121.59	92.97	129.89	391.13	216.45
Earnings From Continuing Operations	658.35	674.72	460.12	2,136	549.2
Minority Interest in Earnings	-35.94	-83.15	-102	-118.31	-95.9
Net Income	622.42	591.57	358.12	2,017	453.3
Net Income to Common	622.42	591.57	358.12	2,017	453.3
Net Income Growth	5.21%	65.19%	-82.25%	345.06%	-
Shares Outstanding (Basic)	2,490	2,570	2,558	2,586	2,518
Shares Outstanding (Diluted)	2,490	2,579	2,558	2,586	2,518
Shares Change (YoY)	-3.46%	0.81%	-1.10%	2.71%	-5.28%
EPS (Basic)	0.25	0.23	0.14	0.78	0.18
EPS (Diluted)	0.25	0.23	0.14	0.78	0.18
EPS Growth	8.70%	64.29%	-82.05%	333.33%	-
Free Cash Flow	721.9	689.5	863.73	309.8	789.3
Free Cash Flow Per Share	0.29	0.27	0.34	0.12	0.31
Dividend Per Share	-	0.200	0.150	0.160	-
Dividend Growth	-	33.33%	-6.25%	-	-
Gross Margin	53.14%	57.88%	58.84%	60.02%	64.66%
Operating Margin	10.96%	10.41%	11.51%	10.26%	9.84%
Profit Margin	9.55%	8.79%	5.97%	30.72%	7.67%
Free Cash Flow Margin	11.08%	10.24%	14.39%	4.72%	13.36%
EBITDA	1,055	1,012	963.34	956.65	847.64
EBITDA Margin	16.20%	15.04%	16.05%	14.56%	14.34%
D&A For EBITDA	340.96	311.51	272.93	282.47	266.07
EBIT	714.24	700.94	690.41	674.18	581.56
EBIT Margin	10.96%	10.41%	11.51%	10.26%	9.84%
Effective Tax Rate	15.59%	12.11%	22.02%	15.48%	28.27%
Revenue as Reported	-	6,733	6,000	6,568	5,909

Source: S&P Global Market Intelligence. Standard template. Financial Sources.